Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

Cited In for PubMed (Select 12520007)

1.

Data-intensive analysis of HIV mutations.

Ozahata M, Sabino E, Diaz R, Cesar-Jr RM, Ferreira J.

BMC Bioinformatics. 2015 Feb 5;16(1):35. [Epub ahead of print]

2.

A SIGNIFICANCE TEST FOR THE LASSO.

Lockhart R, Taylor J, Tibshirani RJ, Tibshirani R.

Ann Stat. 2014 Apr;42(2):413-468.

3.

Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.

Dudley DM, Bailey AL, Mehta SH, Hughes AL, Kirk GD, Westergaard RP, O Connor DH.

Retrovirology. 2014 Dec 23;11(1):122. [Epub ahead of print]

4.

The HIV mutation browser: a resource for human immunodeficiency virus mutagenesis and polymorphism data.

Davey NE, Satagopam VP, Santiago-Mozos S, Villacorta-Martin C, Bharat TA, Schneider R, Briggs JA.

PLoS Comput Biol. 2014 Dec 4;10(12):e1003951. doi: 10.1371/journal.pcbi.1003951. eCollection 2014 Dec.

5.

Estimating HIV-1 fitness characteristics from cross-sectional genotype data.

Gopalakrishnan S, Montazeri H, Menz S, Beerenwinkel N, Huisinga W.

PLoS Comput Biol. 2014 Nov 6;10(11):e1003886. doi: 10.1371/journal.pcbi.1003886. eCollection 2014 Nov.

6.

The lysine 65 residue in HIV-1 reverse transcriptase function and in nucleoside analog drug resistance.

Garforth SJ, Lwatula C, Prasad VR.

Viruses. 2014 Oct 23;6(10):4080-94. doi: 10.3390/v6104080.

7.

A "fuzzy"-logic language for encoding multiple physical traits in biomolecules.

Warszawski S, Netzer R, Tawfik DS, Fleishman SJ.

J Mol Biol. 2014 Dec 12;426(24):4125-38. doi: 10.1016/j.jmb.2014.10.002. Epub 2014 Oct 13.

8.

Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects.

Gupta S, Lataillade M, Kyriakides TC, Chiarella J, St John EP, Webb S, Moreno EA, Simen BB, Kozal MJ.

Viruses. 2014 Sep 16;6(9):3428-37. doi: 10.3390/v6093428.

9.

Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning.

Gönen M, Margolin AA.

Bioinformatics. 2014 Sep 1;30(17):i556-63. doi: 10.1093/bioinformatics/btu464.

10.

Prediction of HIV drug resistance from genotype with encoded three-dimensional protein structure.

Yu X, Weber IT, Harrison RW.

BMC Genomics. 2014;15 Suppl 5:S1. doi: 10.1186/1471-2164-15-S5-S1. Epub 2014 Jul 14.

11.

Identifying selection in the within-host evolution of influenza using viral sequence data.

Illingworth CJ, Fischer A, Mustonen V.

PLoS Comput Biol. 2014 Jul 31;10(7):e1003755. doi: 10.1371/journal.pcbi.1003755. eCollection 2014 Jul.

12.

Sparse Representation for Prediction of HIV-1 Protease Drug Resistance.

Yu X, Weber IT, Harrison RW.

Proc SIAM Int Conf Data Min. 2013;2013:342-349.

13.

Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China.

Xiaobai Z, Xi C, Tian H, Williams AB, Wang H, He J, Zhen J, Chiarella J, Blake LA, Turenchalk G, Kozal MJ.

PLoS One. 2014 Jun 4;9(6):e98740. doi: 10.1371/journal.pone.0098740. eCollection 2014.

14.

The HIVToolbox 2 web system integrates sequence, structure, function and mutation analysis.

Sargeant DP, Deverasetty S, Strong CL, Alaniz IJ, Bartlett A, Brandon NR, Brooks SB, Brown FA, Bufi F, Chakarova M, David RP, Dobritch KM, Guerra HP, Hedden MW, Kumra R, Levitt KS, Mathew KR, Matti R, Maza DQ, Mistry S, Novakovic N, Pomerantz A, Portillo J, Rafalski TF, Rathnayake VR, Rezapour N, Songao S, Tuggle SL, Yousif S, Dorsky DI, Schiller MR.

PLoS One. 2014 Jun 2;9(6):e98810. doi: 10.1371/journal.pone.0098810. eCollection 2014.

15.

The contribution of viral genotype to plasma viral set-point in HIV infection.

Hodcroft E, Hadfield JD, Fearnhill E, Phillips A, Dunn D, O'Shea S, Pillay D, Leigh Brown AJ; UK HIV Drug Resistance Database; UK CHIC Study.

PLoS Pathog. 2014 May 1;10(5):e1004112. doi: 10.1371/journal.ppat.1004112. eCollection 2014 May.

16.

Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis.

Mata-Munguía C, Escoto-Delgadillo M, Torres-Mendoza B, Flores-Soto M, Vázquez-Torres M, Gálvez-Gastelum F, Viniegra-Osorio A, Castillero-Manzano M, Vázquez-Valls E.

BMC Bioinformatics. 2014 Mar 15;15:72. doi: 10.1186/1471-2105-15-72.

17.

Profile of darunavir in the treatment of HIV-infected pediatric and adolescent patients.

Dobroszycki J, Abadi J, Wiznia AA, Rosenberg MG.

Adolesc Health Med Ther. 2011 Sep 14;2:85-93. doi: 10.2147/AHMT.S11177. eCollection 2011. Review.

18.

Residual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolution.

Kauffman RC, Villalobos A, Bowen JH, Adamson L, Schinazi RF.

PLoS One. 2014 Feb 5;9(2):e88258. doi: 10.1371/journal.pone.0088258. eCollection 2014.

19.

New insights into the in silico prediction of HIV protease resistance to nelfinavir.

Antunes DA, Rigo MM, Sinigaglia M, de Medeiros RM, Junqueira DM, Almeida SE, Vieira GF.

PLoS One. 2014 Jan 31;9(1):e87520. doi: 10.1371/journal.pone.0087520. eCollection 2014.

20.

HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study.

Hassan AS, Nabwera HM, Mwaringa SM, Obonyo CA, Sanders EJ, Rinke de Wit TF, Cane PA, Berkley JA.

AIDS Res Ther. 2014 Jan 23;11(1):9. doi: 10.1186/1742-6405-11-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk